João RibasPrincipal at Novo HoldingsSpeaker
João Ribas is a Principal at Novo Holdings and an Executive Director at Orbis Medicines. He focusses on building and launching new therapeutic companies based on novel academic breakthroughs or asset spinouts. He brings operational and strategic experience together with deep scientific understanding. João serves on several boards including Asgard Therapeutics, Tribune Therapeutics, and Orbis Medicines. Prior to joining Novo Holdings, João worked at M Ventures, the corporate venture arm of Merck KGaA, participating in the investments in Plexium and Pantheon Biosciences. João holds a Ph.D. in Bioengineering from the University of Coimbra and performed his doctoral thesis at Harvard Medical School & Brigham and Women's Hospital. He helped start several companies and was the recipient of several entrepreneurial awards.